TGE Value Creative Solutions Corp

This amendment advances the SPAC's IPO process by addressing SEC comments, providing updated financials, and including required exhibits (consents, legal opinions). It brings the registration statement closer to effectiveness, which would allow the SPAC to begin trading and start its search for a business combination target.

This filing provides a completely new blank-check company registration. The filing establishes the trust value ($10.00 per unit), deadline (24 months), sponsor economics (founder shares at $0.004, 25% post-offering stake, 8.3M private warrants at $0.50 each), and the structure for redemption rights (public shareholders can redeem at the IPO price plus accrued interest upon completion of a business combination). No business combination has been identified, and there have been no substantive discussions with any target.

What changed: Annual report on Form 10-K for the fiscal year ended December 31, 2025, filed by TGE Value Creative Solutions Corp (BEBE), a blank check company that completed its IPO on December 22, 2025. This is the company's first 10-K since its IPO. Trust account holds $150,109,781 ($10.01 per public share as of December 31, 2025). Working capital outside trust is $683,798. Net income of $145,831 from inception through year-end, driven by interest income and over-allotment liability change. No business combination has been announced; the company is still searching. Deadline December 22, 2027. No redemptions or extensions have occurred. Why it matters: Establishes baseline financials and trust per-share value. Confirms no deal in progress and that the sponsor (TGE SpiderNet Capital Group, ultimately controlled by AMTD Group) holds 21.9% of shares. Discloses several 5% institutional holders (Lineage Point, Aristeia, AQR, Millennium) which may influence redemptions. Also details conflicts of interest with affiliated entities (TGE, AMTD Digital, AMTD IDEA Group) and the sponsor's ability to indemnify trust. Important for tracking trust erosion and sponsor conduct.

What changed: A joint filing agreement attached to a Schedule 13G/A beneficial ownership report, confirming that Morgan Stanley and Morgan Stanley AIP GP LP will submit a single regulatory disclosure on behalf of both entities unless explicitly differentiated. The exhibit itself does not report adjusted share quantities, acquisition dates, or cost basis. It solely establishes a joint reporting arrangement dated March 06, 2026, executed by Claire Gordon for Morgan Stanley and Craig Krasinski for Morgan Stanley AIP GP LP. Accordingly, it adds no new information concerning redemption windows, trust accounting per share, extension voting procedures, business combination timelines, or sponsor fiduciary conduct. Why it matters: This attachment functions exclusively as a procedural compliance wrapper to satisfy SEC formatting rules for affiliated institutional managers. It makes zero claims regarding customer contracts, revenue streams, addressable markets, technical infrastructure, strategic alliances, active litigation, or key management appointments. Lacking any operational, financial, or structural disclosures, it delivers no incremental data points for investors monitoring shell entity mechanics, capital allocation urgency, or corporate action deadlines.

What changed: Joint Filing Agreement (Exhibit 99.1) to a Schedule 13G beneficial ownership report. The provided text contains only a procedural declaration stating that Morgan Stanley and Morgan Stanley AIP GP LP will file the accompanying Schedule 13G on behalf of both entities. It discloses no share quantities, ownership percentages, acquisition dates, amendment markers, or shifts in voting/investment control. Within the scope of this excerpt, no change in beneficial ownership, transaction activity, or reporting obligation status is recorded. Why it matters: For investors tracking redemption deadlines, trust value, extensions, deal progress, or sponsor conduct, this filing exerts zero mechanical influence. It does not modify any merger timeline, liquidation parameters, or sponsor governance commitments. The agreement merely satisfies SEC joint-filing protocols for multiple affiliated reporting persons, as executed by authorized signatories Claire Gordon for Morgan Stanley and Craig Krasinski for Morgan Stanley AIP GP LP on March 06, 2026. The substantive ownership schedule—which would detail whether a >5% threshold was crossed, amended, or maintained—is omitted from this exhibit. Until the primary 13G body is reviewed, the document offers no signal regarding capital commitment, redemption behavior, or institutional positioning. The text further cautions that intentional misstatements or omissions of fact constitute federal criminal violations under 18 U.S.C. 1001.

What changed: Schedule 13G/A — beneficial ownership report. Lineage Point Capital LP filed an amended Schedule 13G to update its disclosed beneficial ownership position, though the excerpt omits the specific share count, percentage threshold, or transaction date triggering the amendment; the filing contains no assertions regarding the SPAC’s redemption deadline, trust value, extension proceedings, merger timeline, or sponsor conduct. Why it matters: The amendment signals a routine update in institutional holdings that may influence future voting weight or secondary supply, but because Lineage Point Capital LP offers no operational, financial, or strategic commentary in this excerpt, the document bears no material implications for valuation, deal completion risk, or shareholder redemption economics.

What changed: A Joint Filing Agreement (Exhibit A) attached to a Schedule 13G beneficial ownership report, executed on February 17, 2026. Per the agreement, AMTD Group Inc., The Generation Essentials Group, and TGE SpiderNet Capital Group LLC will jointly file Schedule 13G statements regarding Class A ordinary shares of TGE Value Creative Solutions Corp (par value $0.0001 per share). Feridun Hamdullahpur signs as Director for all three entities. Regarding SPAC mechanics, the filing discloses zero changes to the redemption calendar, the $10.17 per-share trust balance, the 2027-12-22 deadline, the SEARCHING status, or sponsor conduct, because it contains neither the underlying Schedule 13G disclosures nor any declarations of acquisition intent, redemption elections, or extension votes. Why it matters: As a routine compliance exhibit, the joint filing consolidates regulatory reporting obligations among affiliated holders, which streamlines how the market tracks their collective voting and disposition rights. According to the document, it does not address customer concentrations, revenue trajectories, total addressable market sizing, technology platforms, commercial partnerships, active litigation, or executive appointments. For investors monitoring the SPAC, this administrative step confirms shared filing infrastructure but yields no actionable intelligence on trust deployment, target negotiation progress, or governance shifts until the complete Schedule 13G body is filed.

What changed: A Schedule 13G beneficial ownership report filed by Aristeia Capital, L.L.C. under Edgar file number 0001172661-26-000897. The provided filing text contains no disclosures regarding redemption deadlines, trust account valuations, extension proposals, business combination milestones, or sponsor conduct. No share quantities, percentage holdings, acquisition dates, or triggering events are included. Why it matters: Because the excerpt limits itself to the document classification and holder identity, it advances no claims about customer concentrations, revenue metrics, total addressable market estimates, corporate strategy, technological capabilities, partnership formations, litigation exposure, or executive movements. In the absence of quantified ownership levels or transaction consideration language, the filing signals neither a material shift in control, altered redemption pressure, nor substantive deal progression, leaving the entity’s SEARCHING status and capital structure mechanics unaffected.

What changed: This document is a Schedule 13G beneficial ownership report [0001167557-26-000018]. According to the filing, it discloses that AQR Capital Management, LLC, AQR Capital Management Holdings, LLC, and AQR Arbitrage, LLC hold beneficial interests in BEBE. Regarding redemption calendars, trust value, extensions, deal progress, and sponsor conduct, the text contains no operational updates. It does not state an ownership percentage, acquisition price, or voting arrangement. It makes no mention of the trust share amount, the stated deadline, any business combination timeline, redemption window parameters, or sponsor amendments. Consequently, nothing in the reported language alters or clarifies the mechanics governing shareholder withdrawals or merger execution. Why it matters: Beyond mechanics, the filing reports no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. The sole substantive item recorded by the filing is the regulatory confirmation that these affiliated AQR entities maintain a reportable position in BEBE. For investors tracking SPAC mechanics, this reflects routine compliance disclosure rather than active deal development, trust accounting, or timeline management. Because the document itself supplies zero numerical breakpoints or calendar markers, it cannot guide redemption timing or target evaluation until the sponsor files definitive proxy materials, tender offer notices, or extension resolutions.

What changed: A Schedule 13G/A routine compliance exhibit filing reporting amendments to beneficial ownership of BEBE common stock. The filing text identifies the submission as a Schedule 13G/A dated 2026-02-10, discloses Lineage Point Capital LP as the reporting holder, and carries SEC file number 0001214659-26-001444, but provides zero share counts, percentage thresholds, transaction dates, or purpose-of-transaction statements. Consequently, the excerpt contains no references bearing on the 2027-12-22 redemption deadline, the cited $10.17 per-share trust amount, any proposed SPAC extension mechanism, pending business combination progress, or sponsor governance conduct. Why it matters: Because the provided excerpt omits the mandatory 13G/A economics—actual beneficial ownership levels, change-in-trigger markers, and investor intent disclosures—it does not supply data to reassess redemption pressure, trust preservation requirements, or proxy/blocker risk relative to the stated deadline and trust reference. According to the filing text alone, no shareholder action thresholds are crossed, no de‑SPAC target is named, and no operational, financial, partnership, litigation, or personnel updates are claimed. Investors tracking the 2027-12-22 liquidation window and the $10.17 trust benchmark will find no immediate mechanical alteration until the full amendment discloses precise holding percentages and strategic intent.

What changed: An 8-K current report containing a press release announcing the commencement of separate trading for the Company’s initial public offering units. According to the press release attached as Exhibit 99.1, the Company announces that starting February 6, 2026, holders may elect to separate their units into Class A ordinary shares and warrants. The Company states that unseparated units will trade as 'BEBE U' on the NYSE, while separated Class A ordinary shares (par value US$0.0001 per share) and whole redeemable warrants (each exercisable for one Class A ordinary share at an exercise price of $11.50) will trade as 'BEBE' and 'BEBE WS.' The filing instructs investors to direct brokers to contact Continental Stock Transfer & Trust Company to execute the split and confirms no fractional warrants will be issued. The document reports no updates to the trust account, redemption calendar, extension provisions, or deal progress. Why it matters: For investors tracking the December 22, 2027 deadline and $10.17 per-share trust value, this filing represents a routine administrative step that does not alter liquidation timelines, redemption pricing, or sponsor conduct. The press release attributes the Company's strategic focus to the media, digital media, entertainment, high fashion, lifestyle, culture, and gaming sectors, stating that operations align with sponsor The Generation Essentials Group (‘TGE’) and its broader developments in multi-media, entertainment, cultural affairs, hospitality, and VIP services. Because the filing merely enables optionality for unit holders before February 6, 2026, it requires no immediate action regarding redemptions or extensions, though it fixes the warrant strike at $11.50 and clarifies transfer agent procedures.

What changed: Schedule 13G beneficial ownership report for Lineage Point Capital LP. The provided excerpt identifies Lineage Point Capital LP as a Schedule 13G filer but omits all quantitative disclosures, including aggregate share counts, acquisition dates, price-paid figures, and percentage-of-outstanding-common calculations. Accordingly, it conveys no information on investor redemption behavior, trust cash positioning, proposed extensions, business-combination milestones, or sponsor governance actions. Why it matters: Because the filer’s submission contains no disclosed purchase timestamps, cost-basis entries, or total-equity percentages, it does not establish a change in controlling interest or a voting bloc capable of influencing proxy outcomes ahead of any stated combination window. Without quantified positions or strategic commentary attributed to Lineage Point Capital LP or the issuer, the excerpt offers no leverage to reassess liquidity expectations, redemption threshold mathematics, or sponsor execution credibility.